Page last updated: 2024-08-25

almagate and Aging

almagate has been researched along with Aging in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cannon, E1
Michels, S; Rosenfeld, PJ; Schmidt-Erfurth, U1
Bailey, C; Imrie, FR1
Behar-Cohen, F; Berdugo, M; Sennlaub, F1
Covell, CA; Graziano, JA; Rich, D; Tobin, KA1
Goldstein, M; Leibovitch, I; Loewenstein, A; Waisbourd, M1

Reviews

3 review(s) available for almagate and Aging

ArticleYear
Managed care opportunities and approaches to supporting appropriate selection of treatment for sight preservation.
    The American journal of managed care, 2019, Volume: 25, Issue:10 Suppl

    Topics: Aging; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Cost-Benefit Analysis; Humans; Intravitreal Injections; Macular Degeneration; Managed Care Programs; Medicare; Off-Label Use; Pharmaceutical Services; Professional Role; Quality-Adjusted Life Years; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; United States; Vascular Endothelial Growth Factor A; Vision Disorders

2019
Promising new treatments for neovascular age-related macular degeneration.
    Expert opinion on investigational drugs, 2006, Volume: 15, Issue:7

    Topics: Aging; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Capillary Permeability; Cholestanols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Double-Blind Method; Drug Design; Drugs, Investigational; Eye Proteins; Humans; Injections; Lactates; Macular Degeneration; Models, Animal; Multicenter Studies as Topic; Neovascularization, Pathologic; Nerve Growth Factors; Pigment Epithelium of Eye; Protein Isoforms; Randomized Controlled Trials as Topic; RNA Interference; RNA, Small Interfering; Serpins; Stilbenes; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vitreous Body

2006
Targeting vascular endothelial growth factor: a promising strategy for treating age-related macular degeneration.
    Drugs & aging, 2007, Volume: 24, Issue:8

    Topics: Aging; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Drug Delivery Systems; Humans; Injections; Macular Degeneration; Ranibizumab; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body

2007

Other Studies

3 other study(ies) available for almagate and Aging

ArticleYear
New treatments for age-related macular degeneration.
    Age and ageing, 2007, Volume: 36, Issue:1

    Topics: Aged; Aged, 80 and over; Aging; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Humans; Light Coagulation; Macular Degeneration; Photochemotherapy; Randomized Controlled Trials as Topic; Ranibizumab; Vascular Endothelial Growth Factor A

2007
[Age-related macular degeneration: therapeutic hopes].
    Medecine sciences : M/S, 2007, Volume: 23, Issue:2

    Topics: Age of Onset; Aged; Aged, 80 and over; Aging; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Double-Blind Method; Female; Genetic Predisposition to Disease; Humans; Macular Degeneration; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ranibizumab; Vascular Endothelial Growth Factor A

2007
New outlook for age-related macular degeneration.
    Nursing, 2007, Volume: 37, Issue:3

    Topics: Aged; Aging; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Fluorescein Angiography; Humans; Light Coagulation; Macular Degeneration; Nursing Assessment; Patient Education as Topic; Photochemotherapy; Ranibizumab; Tomography, Optical Coherence

2007